fluoxetine and oxycodone

fluoxetine has been researched along with oxycodone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
O'Brien, T1
Cheung, SW; Joffe, RT; Otton, SV; Sellers, EM; Wu, D1
Lurcott, G1
Back, I; Taubert, M1
Bykov, K; Gagne, JJ; Yoshida, K; Yunusa, I1

Reviews

2 review(s) available for fluoxetine and oxycodone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone.
    Anesthesia progress, 1998,Fall, Volume: 45, Issue:4

    Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Binding, Competitive; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Enzyme Inhibitors; Fluoxetine; Humans; Hydrocodone; Oxycodone; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors

1998

Other Studies

4 other study(ies) available for fluoxetine and oxycodone

ArticleYear
Phototherapy burns and fluoxetine.
    The Australasian journal of dermatology, 1995, Volume: 36, Issue:2

    Topics: Adult; Burns; Dextropropoxyphene; Female; Fluoxetine; Humans; Oxycodone; Psoriasis; Ultraviolet Therapy

1995
Inhibition by fluoxetine of cytochrome P450 2D6 activity.
    Clinical pharmacology and therapeutics, 1993, Volume: 53, Issue:4

    Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Drug Interactions; Fluoxetine; Humans; In Vitro Techniques; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Multiple Sclerosis; Oxidation-Reduction; Oxycodone; Phenotype; Selective Serotonin Reuptake Inhibitors

1993
Akathisia and an unusual symptomatic treatment: a case report.
    Palliative medicine, 2007, Volume: 21, Issue:8

    Topics: Akathisia, Drug-Induced; Cyclizine; Exercise Therapy; Female; Fluoxetine; Haloperidol; Humans; Methotrimeprazine; Middle Aged; Ovarian Neoplasms; Oxycodone; Palliative Care; Treatment Outcome

2007
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors.
    JAMA network open, 2022, 02-01, Volume: 5, Issue:2

    Topics: Adult; Aged; Analgesics, Opioid; Cohort Studies; Comorbidity; Depression; Emergency Medical Services; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Opiate Overdose; Oxycodone; Pain; Paroxetine; Selective Serotonin Reuptake Inhibitors

2022